학술논문
Urinary bother, Urinalysis, and Two-Year Efficacy Follow-Up Results of Phase I Trial of Intravesical Bacillus Calmette-Guérin Combined with Intravenous Pembrolizumab in Recurrent or Persistent High-Grade Non-Muscle-Invasive Bladder Cancer after Previous Bacillus Calmette-Guérin Treatment
Document Type
Article
Author
Source
In Clinical Genitourinary Cancer June 2024 22(3)
Subject
Language
ISSN
1558-7673